ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03772561
Brief Title: Phase I Study of AZD5363 + Olaparib + Durvalumab in Patients With Advanced or Metastatic Solid Tumor Malignancies (MEDIPAC)

First Submitted : December 10, 2018
First Submitted that Met QC Criteria : December 10, 2018
First Posted : December 11, 2018

Last Update Submitted that Met QC Criteria : December 20, 2018
Last Update Posted : December 24, 2018